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CEA
CAS 
EPD
CAS 
FRS P values
Overall
n 
226
n 
216
n 
53 Overall
CEA/
EPD
CEA/
FRS
ASA therapy 91% 91% 81% .104 .81 .038
Coumadin
therapy
8% 8% 0% .019 .97 .006
CAS, Carotid artery stenting; CAS  EPD, carotid artery stenting plus distal
embolic filter protection;CAS FRS, carotid artery stenting plus flow reversal
system protection; CEA, carotid endarterectomy; CEA/EPD, comparison of
CEA versus CAS EPD; CEA/FRS, comparison of CEA versus CAS FRS.
Table II. Primary events at 30 days
CEA
CAS 
EPD
CAS 
FRS P value
Overall
n 
226
n 
216
n 
53 Overall
CEA/
EPD
CEA/
FRS
MAE 4.0% (8) 5.1% (9) 0.0% (0) .100 .61 .15
Stroke 2.0% (4) 4.0% (7) 0.0% (0) .131 .26 .18
Minor
Stroke
0.5% (1) 3.4% (6) 0.0% (0) .070 .031 .50
Major
Stroke
1.5% (3) 0.6% (1) 0.0% (0) .400 .36 .24
MI 0.0% (0) 0.0% (0) 0.0% (0) - - -
Death (n 
425)
1.5% (3) 1.7% (3) 0.0% (0) .464 .88 .24
CAS, Carotid artery stenting; CAS  EPD, carotid artery stenting plus distal
embolic filter protection;CAS FRS, carotid artery stenting plus flow reversal
system protection; CEA, carotid endarterectomy; CEA/EPD, comparison of
CEA versus CAS EPD; CEA/FRS, comparison of CEA versus CAS FRS.
Endovascular Aneurysm Repair and the Anatomic Severity Grading
Score: A Validation Study with Early Outcomes and Cost Analysis
Sadaf S. Ahanchi, Babatunde H. Almaroof, Jean M. Panneton, Eastern
Virginia Medical School, Norfolk, Va
Background: Endovascular aneurysm repair (EVAR) is an established
alternative to open surgery for the management of abdominal aortic aneurysms
(AAA). It is commonly understood that the anatomic complexity of an aneu-
rysm impacts the technical difficulty of repair. Yet, little research has been done
to correlate the relationship of aneurysm anatomy to technical difficulty and
early outcomes. Additionally, the anatomic diversity of aneurysms makes out-
come comparisons in the literature difficult to interpret. Adjusting for aneurysm
anatomic variability thus provides one method to obtain some measure of
confidence in comparing outcomes in the literature. The objective of adjusting
for anatomic variability is best achieved with scoring schemes incorporating all
factors affecting the outcomes being assessed. Grading scales to define the
severity of anatomic factors have been reported and validated for lower-extrem-
ity peripheral vascular and venous disease. Accordingly in 2002, a system for the
grading of abdominal aortic aneurysms was developed by the Society for
Vascular Surgery/American Association for Vascular Surgery (SVS/AAVS).
The calculated score assumes that the components of the score influence the
difficulty of EVAR. Unfortunately, the correlation of anatomic severity grading
(ASG) score to patient outcomes within a database has yet to be validated.
Accordingly, we provide our experience with calculating ASG score usingM2S
3D image rendering software and provide the practical translation of this score
into early outcomes.
Methods: All patients who underwent an EVAR for infrarenal AAA
between April 2009 and July 2010 by the Division of Vascular Surgery at
Eastern Virginia Medical School were retrospectively identified using CPT
codes 34800, 34803, 34804, and 34805. To minimize the number of con-
founding variables, we limited our study to patients who had placement of a
Talent™ or Aneurx™ endograft (Medtronic®,Minneapolis, MN) and who had
preoperative M2S imaging (M2S©, West Lebanon, NH). Patients who under-
went EVAR for ruptured aneurysm, aortoiliac occlusive disease, or penetrating
abdominal aortic ulcers were excluded. A retrospective chart review of the
electronicmedical record was completed. Recorded patient demographic infor-
mation included age, sex, past medical history, risk factors, and indication for
operation. Indication for operation was defined as either asymptomatic or
symptomatic. All measurements were based on the planned deployment site asdetermined by preoperative imaging. Operative records and postoperative visits
were also examined and intraoperative procedural data and outcomes were
recorded accordingly to the SVS/AAVS guidelines. Lastly, operative supply
costs andhospital charge informationwas obtained from thebillingdepartment.
The total ASG score for each patient was calculated based on aortic neck,
aneurysm, and iliac anatomic factors, such as diameter, length, angulation,
and tortuosity according to the SVS/AAVS guidelines. The mean total ASG
score for the data set was then used to create two independent patient
groups: a low ASG score group (score 14) and a high ASG score group
(score of 14). Both groups were compared for intraoperative and 30-day
outcomes including the use of adjunctive procedures, operating room
supply cost, and hospital charges. Values are given as mean  standard
deviation unless otherwise noted. Fisher exact test and Student t test were
used to compare nominal and continuous variables respectively for the two
independent groups. P value less than .05 was considered statistically significant.
Results:Of the157patientswhounderwentEVARduring the16-month
study period, a total of 108patientsmet our inclusion criteria. The remaining49
patients were excluded because of their ruptured or nonaneurysmal indication
for repair, lack of preoperative M2S imaging, or use of alternative endograft.
The mean time interval between preoperative imaging and EVAR was 3
months. Themean age was 75 years (range 60-88 years). Amajority of patients
were male (78%), Caucasian (81%), and asymptomatic (91%). Seventy-percent
of patients received the Talent endograft and the remaining 30% received the
Aneurx endograft. Ninety-seven percent of patients received bifurcated en-
dografts, while the remaining 3% received uni-iliac endografts. There were 56
patients in the low ASG group and 52 in the high ASG group. Demographic
data, risk factors, indications, and endografts were comparable between the
two groups. Intraoperative outcomes were significantly different in the low
score group vs high score group: operative time (113 minutes vs 210
minutes, P  .0001), blood loss (227 mL vs 866 mL, P  .0002), and
amount of contrast used (100 mL vs 131 mL, P  .032). The low score
group also used an average of three endograft implants during the case,
whereas the high score group used an average of four (P .001). Access site
adjuncts were 14% in the low score group compared to 50% in the high score
group (P  .0001). Endarterectomy, patch angioplasty, and percutaneous
angioplasty were the most common access site adjuncts. Intraoperative
adjuncts were 54% in the low score group vs 80% in the high score group
(P  .004). Distal limb extension, access site management, and iliac artery
occlusive disease management were the most common adjuncts. Seventy-
five percent of these adjuncts were endovascular. EVAR was technically
successful in all patients, with no conversions to an open repair. No statistical
difference in the incidence of graft limb issues such as kinking, twisting, or
stenosis between the two groups were identified (14% low ASG group vs 4%
high ASG group, P  .06). The average length of hospital stay was 3 days.
The average length of hospital stay for the low score groupwas 2 days and for
the high score group was 5 days (P  .012). Postoperatively, our mean
follow-up length was 5 months. There were no deaths within 30 days of the
procedure and no aneurysm related deaths during follow up. Two individ-
uals (3.7%) died during extended follow-up, both belonging to the high
anatomic score group. Total supply cost and charges related to aneurysm
repair also differed based on ASG score. Mean operating room supply cost
was $16,646 for the low score group vs $25,765 for the high score group
(P .006). Mean total hospital charge was $70,956 for the low score group
vs $105,153 for the high score group (P .016). The difference in technical
difficulty of EVAR in the high vs low ASG score group is evident in the
details of the operation. Operative time was 46% longer, 24% more contrast
was used, and blood loss was 74% more in the high anatomic score group.
These results are despite equivalent devices being used. EVAR for the high
vs low ASG score had more endograft implants used (3 vs 4), 36% more
access adjuncts, and 26% more intraoperative adjuncts. The high ASG
category translated into a 55% increase in operating room supply costs and a
48% increase in hospital charges.
Conclusions: The ultimate utility of our study lies in its ability to
provide a framework for interpreting anatomic score into a clinically appli-
cable outcome of anticipated operative difficulty and expected outcomes,
defined by operative time, equipment needs, costs, and early outcomes. We
illustrated that a high anatomic score correlates with increased operating
times, length of hospital stay, blood loss, contrast use, and costs. We
demonstrated that with the use of the M2S software, one is able to quanti-
tatively describe the anatomic severity of aortic aneurysms. This score was an
important indicator of potential technical difficulties requiring more endo-
vascular implants and adjunctive maneuvers during EVAR.
Mesenteric/Celiac Duplex Ultrasound Interpretation Criteria Revisited
Ali F. AbuRahma, Patrick A. Stone,Mohit Srivastava, L. Scott Dean, Tammi
Keiffer, Stephen M. Hass, Albeir Y. Mousa, Robert C. Byrd Health Sciences
Center of West Virgiinia University, Charleston, WV
Background: Several published studies with limited sample size have
reported conflicting results of duplex (DUS) ultrasound utilizing different
threshold velocities in detecting significant stenosis (st.) of SMA or celiac
arteries (CA). This is the largest study to analyze various published diagnos-
tic criteria of SMA/CA st.
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both DUS and arteriography. ROC curves were used to analyze PSV, EDV,
and SMA or CA/aortic PSV ratio in detecting significant st.
Results: For SMA (151 arteries; 67 with 50%, 30 50%, 54 70% st.
based on angiography): Themost accurate PSVs for detecting50% and70%
st. were295 cm/s and400 cm/s with a sensitivity (sens.) of 87% and 72%,
specificity (spec.) 89% and 93%, PPV91% and 84%, andNPV84% and 85%, and
overall accuracy (OA) 88% and 85%, respectively. If Moneta’s criteria were
applied (PSV 275 cm/s for 70% st.) in our series, the sens., spec., PPV, NPV
andOAwere 92%, 59%, 56%, 93%, and 71%, respectively.When a PSVof300
cm/s (Bowersox for 50% st.) was applied, the sens., spec., PPV, NPV, and OA
were 86%, 89%, 91%, 83%, and 87%, respectively. Meanwhile, an EDV of45
cm/s (Zwolak) and70 cm/s (Perko) had a sens. of 79% and 47%, spec. 79%
and 98%, PPV 84% and 97%, NPV 72% and 57%, and OA 79% and 68% for
50% st., respectively. ROCanalysis showed that PSVwas better thanEDVand
SMA/aortic PSV ratio for50% st. of SMA and CA (P .003 and P .0005,
and P  .00001 and P  .04, respectively, Figs 1 and 2). For celiac arteries
(150 arteries; 45 with 50%, 43 50%, and 62 70% st.): The most
accurate PSVs for 50% and 70% st. were 240 cm/s and 320 cm/s
with sens. of 88% and 80%, spec. 83% and 89%, PPV 93% and 84%, NPV 74%
and 86%, and OA 87% and 85%, respectively. If Moneta’s criteria were
applied (PSV  200 cm/s for 70% st.), sens., spec., PPV, NPV, and OA
were 98%, 35%, 52%, 97%, and 61%, respectively.When a PSV of300 cm/s
(Bowersox) was applied, the sens., spec., PPV, NPV, and OA were 72%,
95%, 97%, 59%, and 79% for 50% stenosis. Meanwhile, an EDV of 45
cm/s (Zwolak) and 70 cm/s (Perko) had a sens. of 80% and 62%, spec.
58% and 88%, PPV 82% and 92%, NPV 53% and 49%, and OA 73% and 70%
for 50% st., respectively.
Conclusions: PSV values can be used in detecting significant SMA/CA
stenosis and were better than EDVs and ratios in detecting 50% st. of SMA
and CA. Previously published data must be validated in individual vascular labs.Impact of Metabolic Syndrome on SFA Interventions
Christopher J. Smolock, Javier Anaya Ayala, Jean Bismuth, Joseph J.
Naoum, Hosam F. El-Sayed, Heitham Hassoun, Eric K. Peden, Alan B.
Lumsden, Mark G. Davies, The Methodist Hospital, DeBakey Heart and
Vascular Center, Houston, Tex
Background: Metabolic syndrome (Met Syn) is an epidemic in the
United States and is associated with early onset of atherosclerosis, increased
thrombotic events and increased complications after cardiovascular inter-
vention. Met Syn is found in 50% of patients with peripheral vascular
disease however its impact on peripheral interventions is unknown. The aim
of this study is to determine the outcomes of superficial femoral artery (SFA)
interventions in patients with and without metabolic syndrome.
Methods: A database of patients undergoing endovascular treatment
of the SFA arteries between 1999 and 2009 was retrospectively queried.Met
Syn was defined as the presence of 3 of the following criteria: Blood
pressure 130 mmHg/ 85 mmHg; Triglycerides 150 mg/dL; HDL
 50 mg/dL for women and  40 mg/dL for men; Fasting blood glucose
 110 mg/dL; or body mass index (BMI)  30 kg/m2. Kaplan-Meier
survival analyses were performed to assess time-dependent outcomes. Factor
analyses were performed using a Cox proportional hazard model for time
dependent variables.
Results: One thousand fourteen limbs in 870 patients (64% male)
(average age 67 years) underwent endovascular treatment for symptomatic
SFA disease. Forty six percent met the criteria for Met Syn. Met Syn patients
were more likely to be female and to present with critical ischemia (rest
pain/tissue loss) and have more advanced TASC II SFA lesions (Table).
Mortality was equivalent but morbidity was higher in the Met Syn group.
The presence of Met Syn was associated with a decrease in clinical efficacy as
determined by freedom from recurrent symptoms, decreased primary pa-
tency, and an increase in major amputations (Table).
No Met Syn Met Syn P value
Number limbs at risk (n) 542 464 -
Male gender (%) 69 56 .001
Claudication (%) 62 46 .001
Rest pain/tissue loss (%) 38 54
TASC-II C and D lesions (%) 31 51 .001
30-day mortality (%) 1.3 0.2 .08
Morbidity (%) 9 14 .03
5-y freedom from recurrent symptoms (%) 73 67 .03
5-y primary patency (%) 66 56 .008
5-y assisted primary patency (%) 78 71 .06
5-y secondary patency (%) 78 71 .12
5-y limb salvage rate 87 78 .02
Conclusions: Met Syn is present in nearly half of patients presenting
with SFA disease. These patients present with more advanced disease and
have poorer symptomatic and functional outcomes compared to those
patients without Met Syn. Met Syn should be considered a risk factor for
poor outcomes during SFA interventions.
Surgical Site Infection after Arterial Intervention with a Groin Incision
Alexander J. Boyle, Justin M. Rizer, Kelley D. Hodgkiss-Harlow, Paul A.
Armstrong, Dennis F. Bandyk, University of South Florida, Tampa, Fla
Background: To investigate surgical site infection (SSI) statistics after
arterial interventions requiring a groin incision (a known risk factor for SSI);
including the influence of therapeutic vs prophylactic antibiotics, medical
comorbidities associated with SSI, causative microbiology, and treatment
outcomes.
Methods:A 1-year (2009) retrospective, consecutive-case audit of 372
lower limb arterial interventions (bypass grafting, n 236; AAA, stent graft,
n  86; endarterectomy/repair, n  50) requiring a groin incision. Occur-
rence of SSI within 30 days was correlated with age, gender, body mass
index, procedural therapeutic (active infection at time of procedure) vs
prophylactic (24 hours) antibiotic administration, medical comorbidities
(diabetes, renal insufficiency, coronary artery disease), and the presence of
methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization. In
the prophylactic patient group (n  311), the effect of adding an MRSA
antibiotic (vancomycin, 15-20 mg/kg - 2 doses; daptomycin, 6 mg/kg -
1-dose) to cephalosporin prophylaxis on SSI rate was analyzed.
Results: The overall SSI rate was 15%; higher (P  .001) in patients
receiving therapeutic (29%; 18 of 61) vs prophylactic (12%; 38 of 311)
antibiotics. Nasal MRSA colonization was associated with2 increase in SSI
(37% vs 16%; P  .01). SSI was lowest after open/EVAR AAA repair (5%)
compared to arterial bypass (21%) or endarterectomy/repair (20%) proce-
dures. The majority (64%) of SSIs were caused by gram  bacteria with
MRSA isolated from 37% of all positive cultures. The SSI rate in patients
receiving prophylactic antibiotics was 19% in the cephalosporin (cefazolin or
